Dental Pulp Exposure Clinical Trial
— MTAOfficial title:
Mineral Trioxide Aggregate (MTA) vs. Calcium Hydroxide (CaOH) in Direct Pulp Capping in NW PRECEDENT (Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry Practices.
Verified date | May 2015 |
Source | Oregon Health and Science University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents
Status | Completed |
Enrollment | 376 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 7 Years and older |
Eligibility |
Inclusion Criteria: 1. Any patient 7 years old or older who requires a direct pulp cap of a permanent tooth. 2. The tooth must exhibit a vital pulp upon exposure. 3. The exposure can be due to mechanical, traumatic or carious causes. 4. Patient will be available for the two year follow-up period. Exclusion Criteria: 1. Any primary tooth requiring a direct pulp cap. 2. Tooth demonstrates any radicular radiolucency on a radiograph. 3. Tooth exhibits spontaneous pain. 4. Tooth exhibits lingering (more than 5 seconds) pain to temperature or biting stimulus. 5. Non-English and/or non-Spanish speaking subjects. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health & Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University | National Institute of Dental and Craniofacial Research (NIDCR), University of Washington |
United States,
Hilton TJ, Ferracane JL, Mancl L; Northwest Practice-based Research Collaborative in Evidence-based Dentistry (NWP). Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial. J Dent Res. 2013 Jul;92(7 Suppl):16S-22S. doi: 10.1 — View Citation
Hilton TJ. Keys to clinical success with pulp capping: a review of the literature. Oper Dent. 2009 Sep-Oct;34(5):615-25. doi: 10.2341/09-132-0. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tooth Survival | No recommendation for tooth extraction or root canal therapy. Only one tooth was enrolled/assessed per participant. | Up to two years | No |
Secondary | Pulp Vitality | No evidence of pulpal resorption or calcification or periradicular radiolucency | Up to two years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02019563 -
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
|
Phase 2 | |
Not yet recruiting |
NCT04330768 -
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
|
N/A | |
Completed |
NCT02789423 -
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
|
N/A | |
Completed |
NCT01468480 -
Human Pulpal Response After Pulp Capping With Four Different Agents
|
Phase 2/Phase 3 | |
Completed |
NCT02487329 -
The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping
|
N/A | |
Completed |
NCT00187850 -
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
|
N/A | |
Completed |
NCT03631511 -
Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA
|
N/A | |
Completed |
NCT02492841 -
Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth
|
Phase 2/Phase 3 |